ZIOPTAN (Akorn, Inc.)
Welcome to the PulseAid listing for the ZIOPTAN drug offered from Akorn, Inc.. This Prostaglandin Analog [EPC],Prostaglandin Receptor Agonists [MoA],Increased Prostaglandin Activity [PE],Prostaglandins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Akorn, Inc. |
| NON-PROPRIETARY NAME: | tafluprost |
| SUBSTANCE NAME: | TAFLUPROST |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Prostaglandin Analog [EPC],Prostaglandin Receptor Agonists [MoA],Increased Prostaglandin Activity [PE],Prostaglandins [Chemical/Ingredient] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-11-26 |
| END MARKETING DATE: | 0000-00-00 |
ZIOPTAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZIOPTAN from Akorn, Inc. |
| LABELER NAME: | Akorn, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.0045(mg/.3mL) |
| START MARKETING DATE: | 2014-11-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17478-609_557072c3-98c9-43f6-aa5d-41ec340b32f8 |
| PRODUCT NDC: | 17478-609 |
| APPLICATION NUMBER: | NDA202514 |
Other TAFLUPROST Pharmaceutical Manufacturers / Labelers:
